Used as a key intermediate in the synthesis of antiviral agents, particularly in the development of hepatitis C virus (HCV) inhibitors. Its structure enables selective binding to viral enzymes, making it valuable in creating protease or polymerase inhibitors. The compound's chiral center and functional groups support high specificity and potency in drug design, especially in orally available therapeutics. It is also employed in medicinal chemistry research to optimize pharmacokinetic properties such as metabolic stability and bioavailability.